13F HOLDINGS REPORT (Amended)
Catalys Pacific, LLC
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0001104659-25-077579
Total Value
$148.7M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc. | MLYS | 8,903,838 | $141.4M | 95.08% |
| 2 | Phathom Pharmaceuticals, Inc. | PHAT | 1,167,114 | $7.3M | 4.92% |